Table 6.
Cox Regression Analysis for Prediction or Relapse in ALL Cases
No relapse | Relapse | Univariable | Multivariable | ||||||
---|---|---|---|---|---|---|---|---|---|
N=43 | N=8 | p | OR | 95% CI | p | OR | 95% CI | ||
Age | Mean ±SD | 33.6 ±11.1 | 36.4 ±10.2 | 0.166 | 1.023 | 0.991- 1.056 | |||
Males | N | 26 | 7 | 1 | |||||
% | 60.50% | 87.50% | |||||||
Females | N | 17 | 1 | 0.142 | 0.452 | 0.157- | |||
% | 39.50% | 12.50% | 1.304 | ||||||
BM blasts% | Median | 80 | 80 | 0.514 | 0.988 | 0.952-1.025 | |||
IQR | 70-90 | 70-88 | |||||||
LDH (U/L) | Median | 607 | 402 | 0.339 | 0.999 | 0.998-1.001 | |||
IQR | 435-930 | 176-977 | |||||||
Standard cytogenetic risk | N | 17 | 2 | 1 | |||||
% | 39.50% | 25.00% | |||||||
High cytogenetic risk | N | 26 | 6 | 0.431 | 1.44 | 0.580-3.575 | |||
% | 60.50% | 75.00% | |||||||
Philadelphia negative | N | 34 | 5 | 1 | |||||
% | 79.10% | 62.50% | |||||||
Philadelphia positive | N | 9 | 3 | 0.326 | 1.585 | 0.632-3.974 | |||
% | 20.90% | 37.50% | |||||||
Cortactin expression | Median | 3 | 10.3 | 0.012 | 1.065 | 1.014-1.119 | 0.005 | 1.428 | 1.175-1.783 |
IQR | 1.4-5.3 | 5.4-17.3 | |||||||
HS1 expression | Median | 19.7 | 47.1 | 0.001 | 1.088 | 1.035-1.143 | 0.003 | 1.078 | 1.025-1.134 |
IQR | 16-27.9 | 25.5-58.7 |
OR, odds ratio; CI, confidence interval.